In a new job - October 17, 2017
Annexin appoints Jamal El-Mosleh as new CEO
Annexin Pharmaceuticals has appointed Jamal El-Mosleh as new CEO of the company, and he started his new position on October 16th. Jamal El-Mosleh has a MSc in Industrial Economics with focus on biotechnology from the Chalmers University of Technology and a Master from Chalmers School of Entrepreneurship (Biotechnology). He has previously had a position as […]
In a new job - October 17, 2017
Bastian Dehmel appointed new CMO of OxThera
OxThera announces the appointment of Dr. Bastian Dehmel as their new Chief Medical Officer. Dehmel joins OxThera after serving as Executive Medical Director and Global Development Leader for Amgen’s calcimimetic franchise. He has extensive experience in the life science sector, having led Medical Affairs and Clinical Development teams responsible for drugs in Diabetes and End Stage Renal Disease. Bastian […]
In a new job - October 13, 2017
Helena Brandt is new Head of HR at Bonesupport
BONESUPPORTTM has appointed Helena L Brandt as its new Head of Human Resources. Her appointment is to meet the demands of a fast moving market and the growing professional global leadership team. Reporting directly to CEO Richard Davies Helena will join the Executive Leadership Team. Helena L Brandt has more than 20 years of HR […]
In a new job - October 12, 2017
Nexstim changes its management team
Hanna Kotola, Vice President of Legal Affairs, has been appointed to undertake the wider role of Quality & Regulatory Affairs, in addition to her current role at Nexstim. Hanna will assume the new position of Vice President Legal, Quality & Regulatory Affairs with immediate effect. She joined Nexstim in June 2017 as Vice President of […]
In a new job - September 15, 2017
New Director of Biopharmaceuticals and ATMPs at NDA
Dr Paula Salmikangas, former chair of EMA Committee for Advanced Therapies (CAT), has joined the NDA Advisory Board as Director of Biopharmaceuticals and ATMPs. Dr Salmikangas has a Ph.D. in muscle cell biology and extensive knowledge in biological medicinal products, especially advanced therapy medicinal products and CMC aspects of biopharmaceuticals. Her main research has focused on cell […]
In a new job - September 15, 2017
Kåre Schultz new CEO of Teva
Teva Pharmaceutical Industries has announced that its Board of Directors has named Kåre Schultz to become the company’s President and Chief Executive Officer. Schultz will succeed Dr. Yitzhak Peterburg, who will continue to serve as Interim Chief Executive Officer until Mr. Schultz joins the company. Schultz will be relocating to Israel and based out of the company’s Petah Tikva headquarters. Mr. […]
